Reported 0 shares, down 3,210,802 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-03-31 | 3995000 |
| 2021-06-30 | 3448000 |
| 2021-09-30 | 10837000 |
| 2021-12-31 | 10106000 |
| 2022-03-31 | 5699000 |
| 2022-06-30 | 3744000 |
| 2022-09-30 | 2872000 |
| 2022-12-31 | 1444861 |
| 2023-03-31 | 1091673 |
| 2023-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | Reduced | 0 | -3,210,802 (-100.0%) | 0 | $0 | 2023-08-14 | |
| Q1 2023 | Unchanged | 3,210,802 | 0 (0.0%) | < 0.01% | $1,091,673 | 2023-05-15 | |
| Q4 2022 | Reduced | 3,210,802 | -53,369 (-1.6%) | < 0.01% | $1,444,861 | 2023-02-10 | |
| Q3 2022 | Added | 3,264,171 | +7,840 (0.2%) | < 0.01% | $2,872,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 3,256,331 | 0 (0.0%) | < 0.01% | $3,744,000 | 2022-08-12 | |
| Q1 2022 | Added | 3,256,331 | +137,159 (4.4%) | < 0.01% | $5,699,000 | 2022-05-13 | |
| Q4 2021 | Added | 3,119,172 | +416,547 (15.4%) | < 0.01% | $10,106,000 | 2022-02-14 | |
| Q3 2021 | Added | 2,702,625 | +600,128 (28.5%) | < 0.01% | $10,837,000 | 2021-11-12 | |
| Q2 2021 | Unchanged | 2,102,497 | 0 (0.0%) | < 0.01% | $3,448,000 | 2021-08-13 | |
| Q1 2021 | Added | 2,102,497 | +203,317 (10.7%) | < 0.01% | $3,995,000 | 2021-05-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
61 managers reported LEAP THERAPEUTICS INC for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Artal Group S A | Reduced | 0 | -4,000,000 | 0 | $0 | 14 qtrs |
| CAPTRUST FINANCIAL ADVISORS | Reduced | 0 | -10,000 | 0 | $0 | 7 qtrs |
| TWO SIGMA ADVISERS LP | Reduced | 0 | -27,400 | 0 | $0 | 13 qtrs |
| COMMUNITY TRUST & INVESTMENT CO | Reduced | 0 | -13,650 | 0 | $0 | 7 qtrs |
| BNP PARIBAS FINANCIAL MARKETS | Reduced | 0 | -1 | 0 | $0 | 7 qtrs |
| Bank of America Corporation | Reduced | 0 | -206 | 0 | $0 | 10 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 0 | -152,931 | 0 | $0 | 16 qtrs |
| DONALDSON CAPITAL MANAGEMENT LLC | Reduced | 0 | -10,000 | 0 | $0 | 8 qtrs |
| RAYMOND JAMES & ASSOCIATES | Reduced | 0 | -29,678 | 0 | $0 | 7 qtrs |
| PERCEPTIVE ADVISORS LLC | Reduced | 0 | -6,726,496 | 0 | $0 | 14 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 14, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.